PHARMERICA CORP's ticker is PMC and the CUSIP is 71714F104. A total of 162 filers reported holding PHARMERICA CORP in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $459,000 | -7.8% | 16,043 | -9.8% | 0.04% | -14.0% |
Q1 2014 | $498,000 | +19.1% | 17,786 | -8.6% | 0.04% | +26.5% |
Q4 2013 | $418,000 | +62.0% | 19,458 | 0.0% | 0.03% | +47.8% |
Q3 2013 | $258,000 | -4.4% | 19,458 | 0.0% | 0.02% | 0.0% |
Q2 2013 | $270,000 | – | 19,458 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Smith, Graham & Co., Investment Advisors, LP | 372,169 | $8,229,000 | 1.08% |
LOMBARDIA CAPITAL PARTNERS LLC | 839,636 | $18,564,000 | 0.96% |
Malaga Cove Capital, LLC | 45,139 | $998,000 | 0.82% |
Endurant Capital Management LP | 99,490 | $2,200,000 | 0.71% |
Phocas Financial Corp. | 262,430 | $5,802,000 | 0.45% |
Century Capital Management, LLC | 154,646 | $3,419,000 | 0.38% |
Personal Capital Advisors Corp | 325,099 | $7,188,000 | 0.33% |
FULLER & THALER ASSET MANAGEMENT, INC. | 718,292 | $15,881,000 | 0.31% |
ENDICOTT MANAGEMENT CO | 30,000 | $663,000 | 0.23% |
Convergence Investment Partners, LLC | 70,550 | $1,560,000 | 0.19% |